Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacodynamic Equivalence of Amneal Albuterol vs ProAir HFA in Mild Asthma
NCT03549897Phase 3Unknown
- Sponsor
- Amneal Pharmaceuticals, Inc.
- Start
- Mar 2018
- Primary completion
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of salbutamol in asthma, sponsored by Amneal Pharmaceuticals, Inc.. Status: unknown.
02
Drugs
salbutamol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT03549897.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03549897.